Skip to main content
Clinical Trials/NCT06463990
NCT06463990
Active, not recruiting
Not Applicable

Association Between the Triglyceride-glucose Index and the Ratio of Triglyceride to High-density Lipoprotein Cholesterol With Fetal Macrosomia in Low-risk Nulliparous Pregnant Women

Ankara Etlik City Hospital1 site in 1 country302 target enrollmentJanuary 1, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Fetal Macrosomatia
Sponsor
Ankara Etlik City Hospital
Enrollment
302
Locations
1
Primary Endpoint
The triglyceride to high density lipoprotein cholesterol ratio
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

Metabolic disorders that can occur during pregnancy, in particular disorders of lipid metabolism and insulin resistance, can have a detrimental effect on pregnancy and the fetus.

The triglyceride level and other lipids increase slightly during pregnancy. This increase has a positive effect on the development of the fetus. However, an excessive increase in lipid levels can cause some metabolic disorders such as gestational diabetes and increase feto-maternal morbidity/mortality.

While some existing studies have shown that elevated triglyceride levels can cause fetal macrosomia, others have found no correlation between these two variables. The ratio of triglycerides to HDL is a widely used marker for lipid disorders. In addition, the triglyceride-glucose index is also an index used to detect insulin resistance.

Detailed Description

In this study, the investigators aimed to investigate whether the ratio of triglycerides to high-density lipoprotein cholesterol and the triglyceride glucose index are associated with fetal macrosomia in low-risk nulliparous pregnant women.

Registry
clinicaltrials.gov
Start Date
January 1, 2023
End Date
July 31, 2024
Last Updated
last year
Study Type
Observational
Sex
Female

Investigators

Sponsor
Ankara Etlik City Hospital
Responsible Party
Principal Investigator
Principal Investigator

Fahri Burcin Firatligil

Specialist doctor in obstetrics and gynecology and Fellow student in Perinatology

Ankara Etlik City Hospital

Eligibility Criteria

Inclusion Criteria

  • Screening for fetal macrosomia was based on the term defined according to the standards of the American College of Obstetricians and Gynecologists (ACOG).
  • Low-risk nulliparous singleton pregnant women.
  • Age between 18 and 40 years old

Exclusion Criteria

  • Post-term pregnancies
  • Hospitalized for preterm labor or preterm premature rupture of membranes.
  • Gestational diabetes mellitus, diabetes mellitus type I - type II.
  • Pregnant women with fetal growth restriction, hypertensive pregnancy disorders, familial hypercholesterolemia and hyperlipidemia.
  • Multiparous pregnant women
  • Multiple pregnancies
  • Pregnant women with chronic diseases.
  • Pregnant women with impaired liver function;
  • Pregnant women with body mass index \<25 and \>40 kg/m2.

Outcomes

Primary Outcomes

The triglyceride to high density lipoprotein cholesterol ratio

Time Frame: between 28 and 40 weeks of pregnancy

The triglyceride to high density lipoprotein cholesterol ratio was calculated from the blood samples taken from pregnant women in the third trimester.

The TyG index

Time Frame: between 28 and 40 weeks of pregnancy

The triglyceride-glucose index was determined using the formula Ln \[fasting triglycerides (mg/dL) × fasting plasma glucose (mg (dL)/2\], with blood samples taken from pregnant women in the third trimester.

Secondary Outcomes

  • HOMA-IR(between 28 and 40 weeks of pregnancy)

Study Sites (1)

Loading locations...

Similar Trials